Aberrant expressions of cyclin-D, cyclin-E, and cyclin-A are common in cancer cells.(Gallo et al. 2022) Cyclin/CDK complexes undergo specific changes in their activity during different stages of the cell cycle, ensuring proper cell cycle progression. The gene discussed is CCNE1; the disease is cancer.